TAOX
Price:
$6.67
Market Cap:
$23.26M
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Industry
Biotechnology
IPO Date
2025-07-02
Stock Exchange
NASDAQ
Ticker
TAOX
According to TAO Synergies Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 20.51. This represents a change of -53.39% compared to the average of 44.01 of the last 4 quarters.
The mean historical Current Ratio of TAO Synergies Inc. over the last ten years is 17.95. The current 20.51 Current Ratio has changed 11.33% with respect to the historical average. Over the past ten years (40 quarters), TAOX's Current Ratio was at its highest in in the March 2025 quarter at 72.71. The Current Ratio was at its lowest in in the June 2024 quarter at 2.98.
Average
17.95
Median
17.63
Minimum
7.14
Maximum
29.39
Discovering the peaks and valleys of TAO Synergies Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.71%
Maximum Annual Current Ratio = 29.39
Minimum Annual Increase = -75.71%
Minimum Annual Current Ratio = 7.14
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 17.47 | 144.71% |
| 2023 | 7.14 | -75.71% |
| 2022 | 29.39 | 65.15% |
The current Current Ratio of TAO Synergies Inc. (TAOX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
18.00
5-year avg
17.95
10-year avg
17.95
TAO Synergies Inc.’s Current Ratio is greater than Sonnet BioTherapeutics Holdings, Inc. (0.26), greater than Rallybio Corporation (9.98), greater than Plus Therapeutics, Inc. (1.29), greater than Intensity Therapeutics, Inc. (3.60), greater than iBio, Inc. (8.39), greater than Boundless Bio, Inc. (14.08), greater than NextCure, Inc. (3.71), less than Klotho Neurosciences, Inc. (83.69), greater than Iterum Therapeutics plc (2.13), greater than Cadrenal Therapeutics, Inc. Common Stock (3.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.26 | $8.43M | |
| 9.98 | $28.16M | |
| 1.29 | $39.62M | |
| 3.60 | $21.70M | |
| 8.39 | $21.16M | |
| 14.08 | $24.62M | |
| 3.71 | $34.11M | |
| 83.69 | $25.82M | |
| 2.13 | $21.14M | |
| 3.02 | $23.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TAO Synergies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TAO Synergies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is TAO Synergies Inc.'s Current Ratio?
How is the Current Ratio calculated for TAO Synergies Inc. (TAOX)?
What is the highest Current Ratio for TAO Synergies Inc. (TAOX)?
What is the 3-year average Current Ratio for TAO Synergies Inc. (TAOX)?
What is the 5-year average Current Ratio for TAO Synergies Inc. (TAOX)?
How does the current Current Ratio for TAO Synergies Inc. (TAOX) compare to its historical average?